ABIN180481

antibody from antibodies-online

Targeting: ERBB2 CD340, HER-2, HER2, NEU, NGL

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

ABIN180481

Provider

antibodies-online

Product name

anti-V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) (C-Term) antibody

Antibody type

Monoclonal

Description

Supernatant

Reactivity

Human

Host

Rabbit

Epitope

C-Term

Isotype

IgG

Antibody clone number

BV5

Vial size

0.5 mL

Storage

Store the antibody (undiluted) at 2-8°C.Shelf life: one year from despatch.

References

Submitted references

HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement.

Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ
American journal of clinical pathology 2000 Feb;113(2):251-8

---

Expression of HER2/erbB-2 correlates with survival in osteosarcoma.

Gorlick R, Huvos AG, Heller G, Aledo A, Beardsley GP, Healey JH, Meyers PA
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999 Sep;17(9):2781-8

---

erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody.

Keshgegian AA, Cnaan A
American journal of clinical pathology 1997 Oct;108(4):456-63

---

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

Wright C, Nicholson S, Angus B, Sainsbury JR, Farndon J, Cairns J, Harris AL, Horne CH
British journal of cancer 1992 Jan;65(1):118-21

---

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

Wright C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH
Cancer research 1989 Apr 15;49(8):2087-90